PrEP trial announced

UK Health Minister Steve Brine has announced the timetable for a major trial into pre-exposure prophylaxis (PrEP) drug Truvada.

Truvada is a pill taken before sex which has already been shown to reduce the risk of infection with HIV in high risk persons by 86%.

The trial is expected to begin during August 2017, and at least 10,000 people are expected to be enrolled over the next three years of the trial.

Up to £10 million has been made available to fund the three year trial.